HUE055132T2 - Virulenciában gyengített baktériumok rosszindulatú szolid tumorok kezelésére - Google Patents
Virulenciában gyengített baktériumok rosszindulatú szolid tumorok kezeléséreInfo
- Publication number
- HUE055132T2 HUE055132T2 HUE16797930A HUE16797930A HUE055132T2 HU E055132 T2 HUE055132 T2 HU E055132T2 HU E16797930 A HUE16797930 A HU E16797930A HU E16797930 A HUE16797930 A HU E16797930A HU E055132 T2 HUE055132 T2 HU E055132T2
- Authority
- HU
- Hungary
- Prior art keywords
- virulence
- treatment
- solid tumors
- malignant solid
- bacteria attenuated
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title 1
- 230000002238 attenuated effect Effects 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 230000001018 virulence Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15195490 | 2015-11-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE055132T2 true HUE055132T2 (hu) | 2021-11-29 |
Family
ID=54697464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE16797930A HUE055132T2 (hu) | 2015-11-19 | 2016-11-17 | Virulenciában gyengített baktériumok rosszindulatú szolid tumorok kezelésére |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US11166987B2 (enExample) |
| EP (2) | EP3903813A1 (enExample) |
| JP (1) | JP7060503B2 (enExample) |
| KR (1) | KR102736981B1 (enExample) |
| CN (1) | CN108472348B (enExample) |
| AU (1) | AU2016358257B2 (enExample) |
| BR (2) | BR122023024697A2 (enExample) |
| CA (1) | CA3003563A1 (enExample) |
| CY (1) | CY1124564T1 (enExample) |
| DK (1) | DK3377094T3 (enExample) |
| EA (1) | EA201890868A1 (enExample) |
| ES (1) | ES2880431T3 (enExample) |
| HR (1) | HRP20211191T1 (enExample) |
| HU (1) | HUE055132T2 (enExample) |
| IL (1) | IL259052B2 (enExample) |
| LT (1) | LT3377094T (enExample) |
| PL (1) | PL3377094T3 (enExample) |
| PT (1) | PT3377094T (enExample) |
| RS (1) | RS62152B1 (enExample) |
| SG (1) | SG11201803643TA (enExample) |
| SI (1) | SI3377094T1 (enExample) |
| SM (1) | SMT202100423T1 (enExample) |
| WO (1) | WO2017085233A1 (enExample) |
| ZA (1) | ZA201803902B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6797025B2 (ja) | 2014-05-21 | 2020-12-09 | ウニヴェルズィテート バーゼル | 細菌に基づくタンパク質送達 |
| KR102689434B1 (ko) | 2015-11-19 | 2024-07-29 | 우니페르시테트 바젤 | 박테리아-기반의 단백질 전달 |
| JP6976351B2 (ja) | 2016-12-20 | 2021-12-08 | ウニヴェルズィテート・バーゼルUniversitat Basel | 弱毒化細菌に基づくタンパク質送達 |
| KR102110993B1 (ko) * | 2018-12-20 | 2020-05-14 | 한국생명공학연구원 | 클레브시엘라 아에로제네스(Klebsiella aerogenes) 균주를 유효성분으로 포함하는 암 진단, 예방 또는 치료용 조성물 |
| AU2021370840A1 (en) * | 2020-10-27 | 2023-06-22 | T3 Pharmaceuticals Ag | Bacteria based protein delivery |
| CN114712496B (zh) * | 2022-04-29 | 2023-10-13 | 中山大学·深圳 | 一种展示新抗原的细菌衍生外膜囊泡疫苗及制备方法和在制备癌症免疫治疗试剂盒中的应用 |
| CN116064877B (zh) * | 2023-02-09 | 2024-09-20 | 宁夏大学 | 利用lamp技术快速检测阴沟肠杆菌的试剂盒及方法 |
| CN116855496B (zh) * | 2023-07-05 | 2024-08-16 | 郑州大学 | 含有干扰序列siRNA-HIF-1α的表达质粒在制备抗肝细胞癌药物中的应用 |
| WO2025037284A2 (en) * | 2023-08-17 | 2025-02-20 | Baccine Ltd. | Genetically modified bacteria for multi-modal secretion of a neoantigen |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965381A (en) * | 1998-03-06 | 1999-10-12 | Ludwig Institute For Cancer Research | Delivery of proteins into eukaryotic cells with recombinant yersinia |
| AU5209399A (en) | 1998-07-10 | 2000-02-01 | Cornell Research Foundation Inc. | Recombinant constructs and systems for secretion of proteins via type iii secretion systems |
| US20020160502A1 (en) | 2000-09-26 | 2002-10-31 | Roger Williams Hospital | Recombinant BCG vaccines for the prevention and treatment of cancer |
| US20040147719A1 (en) | 2001-03-26 | 2004-07-29 | Guy Cornelis | Type III bacterial strains for use in medicine |
| EP1565185A4 (en) | 2002-11-07 | 2011-01-05 | Technion Res & Dev Foundation | NEUROPROTECTIVE IRON CHELATORS AND PHARMACEUTICAL COMPOSITIONS THEREWITH |
| FR2862312B1 (fr) | 2003-11-13 | 2006-02-17 | Univ Grenoble 1 | Outil de transfert et de production de proteines mettant en oeuvre le systeme de secretion de type iii de pseudomonas |
| WO2007044406A2 (en) | 2005-10-04 | 2007-04-19 | Ludwig Institute For Cancer Research | Methods for stimulating an immune response using bacterial antigen delivery system |
| WO2008019183A2 (en) | 2006-05-18 | 2008-02-14 | The Regents Of The University Of California | Biopolymer and protein production using type iii secretion systems of gram negative bacteria |
| TW200819540A (en) * | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| AU2009226972B2 (en) | 2008-03-17 | 2014-05-29 | Gerhard Heusipp | YopM as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions |
| DK2717886T3 (da) | 2011-06-08 | 2021-12-06 | Chelation Partners Incorporated | Metalchelateringssammensætninger og fremgangsmåder til styring af en levende celles eller organismes vækst eller aktiviteter |
| US9127284B2 (en) * | 2012-05-04 | 2015-09-08 | The University Of Hong Kong | Modified bacteria and their uses thereof for the treatment of cancer or tumor |
| EP3049526B1 (en) | 2013-09-24 | 2021-02-24 | Medicenna Therapeutics, Inc. | Interleukin-4 receptor-binding fusion proteins and uses thereof |
| US10143743B2 (en) | 2013-11-18 | 2018-12-04 | Yale University | Non-replicating bacterial nanoparticle delivery system and methods of use |
| JP6797025B2 (ja) | 2014-05-21 | 2020-12-09 | ウニヴェルズィテート バーゼル | 細菌に基づくタンパク質送達 |
| KR102689434B1 (ko) | 2015-11-19 | 2024-07-29 | 우니페르시테트 바젤 | 박테리아-기반의 단백질 전달 |
| JP6976351B2 (ja) | 2016-12-20 | 2021-12-08 | ウニヴェルズィテート・バーゼルUniversitat Basel | 弱毒化細菌に基づくタンパク質送達 |
-
2016
- 2016-11-17 BR BR122023024697-7A patent/BR122023024697A2/pt active Search and Examination
- 2016-11-17 WO PCT/EP2016/078084 patent/WO2017085233A1/en not_active Ceased
- 2016-11-17 RS RS20210926A patent/RS62152B1/sr unknown
- 2016-11-17 EA EA201890868A patent/EA201890868A1/ru unknown
- 2016-11-17 CA CA3003563A patent/CA3003563A1/en active Pending
- 2016-11-17 SM SM20210423T patent/SMT202100423T1/it unknown
- 2016-11-17 PL PL16797930T patent/PL3377094T3/pl unknown
- 2016-11-17 US US15/773,524 patent/US11166987B2/en active Active
- 2016-11-17 DK DK16797930.1T patent/DK3377094T3/da active
- 2016-11-17 CN CN201680079454.XA patent/CN108472348B/zh active Active
- 2016-11-17 HU HUE16797930A patent/HUE055132T2/hu unknown
- 2016-11-17 LT LTEP16797930.1T patent/LT3377094T/lt unknown
- 2016-11-17 PT PT167979301T patent/PT3377094T/pt unknown
- 2016-11-17 HR HRP20211191TT patent/HRP20211191T1/hr unknown
- 2016-11-17 EP EP21170509.0A patent/EP3903813A1/en active Pending
- 2016-11-17 IL IL259052A patent/IL259052B2/en unknown
- 2016-11-17 KR KR1020187016568A patent/KR102736981B1/ko active Active
- 2016-11-17 AU AU2016358257A patent/AU2016358257B2/en active Active
- 2016-11-17 JP JP2018526167A patent/JP7060503B2/ja active Active
- 2016-11-17 BR BR112018009753-5A patent/BR112018009753B1/pt active IP Right Grant
- 2016-11-17 SG SG11201803643TA patent/SG11201803643TA/en unknown
- 2016-11-17 SI SI201631290T patent/SI3377094T1/sl unknown
- 2016-11-17 EP EP16797930.1A patent/EP3377094B1/en active Active
- 2016-11-17 ES ES16797930T patent/ES2880431T3/es active Active
-
2018
- 2018-06-12 ZA ZA2018/03902A patent/ZA201803902B/en unknown
-
2021
- 2021-07-22 CY CY20211100666T patent/CY1124564T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL296080B1 (en) | Method for treating cancer | |
| PL3943093T3 (pl) | Zastosowanie pasteryzowanej akkermansia do leczenia nowotworu złośliwego | |
| IL255261A0 (en) | Methods for treating cancer | |
| LT3594238T (lt) | Antikūno kompozicijos, skirtos navikų gydymui | |
| IL249065A0 (en) | Combination therapies for the treatment of cancer | |
| LT3283527T (lt) | Kompleksinė terapija vėžio gydymui | |
| HUE059694T2 (hu) | Készítmény rák kezelésére | |
| HUE055132T2 (hu) | Virulenciában gyengített baktériumok rosszindulatú szolid tumorok kezelésére | |
| BR112017011771A2 (pt) | métodos e composições para o tratamento de câncer | |
| IL284875A (en) | Lasofoxifene treatment of breast cancer | |
| IL276733A (en) | Use of Aribolin in cancer treatment | |
| LT3200815T (lt) | Būdai ir kompozicijos, skirti vėžio gydymui | |
| KR20180084772A (ko) | 암 치료를 위한 조합 치료법 | |
| EP3474854A4 (en) | DRUG ASSOCIATIONS FOR THE TREATMENT OF CANCER | |
| MA71411A (fr) | Polythérapie pour le traitement de tumeurs malignes | |
| IL248767B (en) | Trimethoxyphenyl-benzaimidazole compounds for cancer treatment | |
| IL251903B (en) | Epilimod for use in the treatment of colon cancer | |
| LT3532067T (lt) | Liposominė vaisto forma, skirta naudoti gydant vėžį | |
| IL265751B (en) | Immunogenic compounds for cancer therapy | |
| LT3534885T (lt) | Farneziltransferazės inhibitoriai, skirti naudoti vėžio gydymui | |
| HUE040167T2 (hu) | Rákkezelés | |
| HUE054998T2 (hu) | Kombinációs terápiák emlõrák kezelésében való alkalmazásra | |
| ZA201707024B (en) | Cancer treatment composition | |
| KR20180084983A (ko) | 암의 치료를 위한 피리미도-피리미다지논의 용도 | |
| EP3407909A4 (en) | CANCER TREATMENT |